SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pierre Mondieu who wrote (27684)2/9/1999 9:19:00 PM
From: Karl Drobnic  Read Replies (1) of 31646
 
Key clients: Bayer gave TAVA 47 factories to remediate if I heard Kevin Fallon correctly. I didn't catch all the names of clients that Kevin mentioned in his presentation. Bayer is impressive because it's Bayer, and because TAVA has worked for a growing list of top notch pharmaceutical companies: Bristol Myers-Squibb, Merck, Johnson & Johnson, Amgen, Glaxo,and probably some I've missed. This is a field that requires special expertise - for example, quality control on production lines. Those tiny holes in the time-release capsules have to be exactly right. No mistakes. That takes machine vision expertise. So each job adds to Tava's growing prominence as a systems integrator to the pharmaceutical sector.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News